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Introduction. Pulmonary vein isolation is an established therapy for symptomatic atrial 
fibrillation (AF). The second generation cryoballoon is effective in achieving pulmonary vein 
isolation. In 2018 we implemented the cryoballoon ablation (CBA) in Republic of Moldova.  
Aim of the study. To assess the freedom from AF recurrence after CBA.  
Materials and methods. A retrospective study was performed in 8 consecutive patients who 
underwent CBA using Arctic Front Advance cryoballoon (Medtronic) for paroxysmal or 
persistent AF from June 2018 till December 2019 in Medpark International Hospital. We 
followed up the patients from June 2018 till March 2020. The information about the clinical 
symptoms and ECG data during follow-up was collected to identify the presence of recurrence. 
A recurrence after CBA was considered AF episode that lasted at least 30 seconds. Continuous 
variables are presented as mean ± SD. Kaplan–Meier analysis was used to determine the 
probability of freedom from AF during follow-up.  
Results. A total number of 8 patients with a mean age of 60.13 ± 6.88 years with paroxysmal 
(n=7; 87.5%) or persistent (n=1; 12.5%) AF were identified. There were 6 males (75%) and 2 
females (25%). All patients had a successful pulmonary vein isolation procedure with 100% of 
veins isolated. No patient had complication during procedure as phrenic nerve palsy, stroke or 
pericardial effusion. After a 3-month blanking period during a mean follow-up of 337 ± 135 
days there were 2 (25%) AF recurrences. One patient developed atrial flutter but not AF in the 
follow-up period with restoration of sinus rhythm with electrical cardioversion. The average 
days before recurrence was 120.5 ± 41.72 (150 and 90). Freedom from AF recurrence was 75% 
at 11,2 months follow-up.  
Conclusions. The second generation cryoballoon ablation is an effective method of treatment 
for atrial fibrillation. Our results are compatible with the success rate that is reported by 
majority of the studies.  
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Background. Acromegaly is a rare endocrine disorder that carries a significant burden of 
cardiovascular morbidity and mortality. Abnormalities of the growth hormone/insulin-like 
growth factor-1 (IGF-1) axis in acromegaly lead to the characteristic cardiovascular 
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manifestations. One hallmark feature of the disease is acromegalic cardiomyopathy; a 
syndrome of progressive cardiac dysfunction characterized by left ventricular (LV) 
hypertrophy, diastolic dysfunction, and combined systolic and diastolic dysfunction in 
advanced stages. Dilated cardiomyopathy (DCM) is relatively rare in this setting but is 
associated with increased mortality.  
Case report. We report the case of a 44 y.o man who was admitted to the cardiology 
department because of progressive dyspnea on exertion and paroxysmal nocturnal dyspnea 
with recent onset. Physical examination revealed systolic murmurs in mitral and tricuspid areas 
and jugular vein distension. Laboratory findings showed moderate hepatic cytolysis. 
Electrocardiogram showed sinus rhythm (SR) and LV hypertrophy. Echocardiography 
revealed DCM with severe LV dysfunction (LV ejection fraction (LVEF) = 20%), LV 
hypertrophy, restrictive diastolic dysfunction, biatrial enlargement, moderate mitral 
regurgitation and pulmonary hypertension (systolic pulmonary artery pressure (PAPs) = 60 
mmHg). A coronary angiography was performed to rule out coronary disease. It revealed 
normal coronary arteries. Optimal heart failure (HF) treatment was started. The patient did not 
attend follow-up visits. Ten years later, he presented with NYHA class III HF symptoms. 
Mandibular enlargement with widened space between the lower incisor teeth, macroglossia, 
enlargement of his hands and feet over the last 10 years was noted on physical examination. 
Laboratory findings revealed hepatic cytolysis and elevated NT-proBNP (9668 pg/ml). 
Electrocardiogram identified atrial fibrillation. Echocardiography showed dilated 
cardiomyopathy with further deterioration of LV function (LVEF=15%) and pulmonary 
hypertension. Magnetic resonance imaging showed non-specific LV myocardial fibrosis. 
Genetic tests, carried out to exclude a genetic DCM (170 genes evaluated), did not identify any 
pathogenic variants. At this point an endocrinology evaluation was requested. It revealed active 
acromegaly (IGF-I = 416 ng/ml) due to pituitary microadenoma. Considering a high surgical 
risk, conservative treatment with somatostatin analogue was initiated. Follow up at 5, 10 and 
18 months revealed improved clinical status, spontaneous restauration of SR, progressive 
improvement in LVEF (30%, 33% and 40%), normalization of PAPs and of NT-proBNP = 186 
pg/ml.  
Conclusions. Here we report the case of a patient with acromegaly and severe non-ischemic 
DCM. Treatment with somatostatin analogue resulted in early improvement of clinical status 
and LV systolic function sustaining a probable causal relation between endocrinological 
dysfunction and DCM. This is a one of the few reported cases of acromegalic DCM with 
significant improvement under somatostatin analogue therapy as an initial option.  
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Background. Rheumatic mitral stenosis (MS) is associated with left atrium (LA) thrombus in 
patients in sinus rhythm (3 % – 13 %) and markedly increases in atrial fibrillation (~33 %).The 
presence of LA thrombus carries a risk of systemic embolization and neurologic morbidity. 
